4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0002034679-25-000006
Chief Medical Officer sold 11,000 shares at an average $18.65 ($205,108)
- Chief Medical Officer acquired 11,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Raben David Chief Medical Officer | 2025-11-24 | Option exercise 10b5-1 | +5,500 | $3.79 | $20,844 | 40,997 | D |
| Raben David Chief Medical Officer | 2025-11-24 | Sale 10b5-1 | −5,500 | $18.45 | $101,475 | 35,497 | D |
| Raben David Chief Medical Officer | 2025-11-25 | Option exercise 10b5-1 | +4,594 | $3.79 | $17,410 | 40,091 | D |
| Raben David Chief Medical Officer | 2025-11-25 | Sale 10b5-1 | −4,594 | $18.84 | $86,562 | 35,497 | D |
| Raben David Chief Medical Officer | 2025-11-25 | Option exercise 10b5-1 | +906 | $3.79 | $3,434 | 36,403 | D |
| Raben David Chief Medical Officer | 2025-11-25 | Sale 10b5-1 | −906 | $18.84 | $17,071 | 35,497 | D |
| Derivatives | |||||||
| Raben David Chief Medical Officer | 2025-11-24 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,500 | 123,370 | D | ||
| Raben David Chief Medical Officer | 2025-11-25 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,594 | 118,776 | D | ||
| Raben David Chief Medical Officer | 2025-11-25 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −906 | 69,413 | D | ||
| Open-market sales · 11,000 sh · avg $18.65 · $205,108 | |||||||
Loading xslF345X05/wk-form4_1764113985.xml…